P

Inventor

BAKER BRENDA F

US37 patents
⚠️ This page may combine multiple inventors who share the name “BAKER BRENDA F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ISIS PHARMACEUTICALS INC

27 patents
US7339051B2Mar 4, 2008

Compositions and methods for the treatment of severe acute respiratory syndrome (SARS)

ISIS PHARMACEUTICALS INC158 citations98
US6210892B1Apr 3, 2001

Alteration of cellular behavior by antisense modulation of mRNA processing

ISIS PHARMACEUTICALS INC358 citations98
US8361977B2Jan 29, 2013

Compositions and methods for modulation of SMN2 splicing

ISIS PHARMACEUTICALS INC62 citations97
US7321828B2Jan 22, 2008

System of components for preparing oligonucleotides

ISIS PHARMACEUTICALS INC216 citations96
US6228642B1May 8, 2001

Antisense oligonucleotide modulation of tumor necrosis factor-(α) (TNF-α) expression

ISIS PHARMACEUTICALS INC91 citations96
US6007995ADec 28, 1999

Antisense inhibition of TNFR1 expression

ISIS PHARMACEUTICALS INC88 citations96
US6080580AJun 27, 2000

Antisense oligonucleotide modulation of tumor necrosis factor-α (TNF-α) expression

ISIS PHARMACEUTICALS INC86 citations94
US6171860B1Jan 9, 2001

Antisense inhibition of rank expression

ISIS PHARMACEUTICALS INC18 citations93
US7919612B2Apr 5, 2011

2′-substituted oligomeric compounds and compositions for use in gene modulations

ISIS PHARMACEUTICALS INC14 citations92
US6372433B1Apr 16, 2002

Antisense modulation of inhibitor of DNA binding-1 expression

ISIS PHARMACEUTICALS INC22 citations92
US7884086B2Feb 8, 2011

Conjugates for use in hepatocyte free uptake assays

ISIS PHARMACEUTICALS INC21 citations90
US7812149B2Oct 12, 2010

2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations

ISIS PHARMACEUTICALS INC12 citations84
US6054316AApr 25, 2000

Antisense inhibition of ETs-2 expression

ISIS PHARMACEUTICALS INC17 citations84
US8946183B2Feb 3, 2015

Compositions and methods for modulation of SMN2 splicing

ISIS PHARMACEUTICALS INC12 citations83
US6159734ADec 12, 2000

Antisense modulation of peroxisome proliferator-activated receptor gamma expression

ISIS PHARMACEUTICALS INC16 citations83
US7790691B2Sep 7, 2010

Double stranded compositions comprising a 3′-endo modified strand for use in gene modulation

ISIS PHARMACEUTICALS INC12 citations82
US6015712AJan 18, 2000

Antisense modulation of FADD expression

ISIS PHARMACEUTICALS INC15 citations74
US6001652ADec 14, 1999

Antisense modulation of cREL expression

ISIS PHARMACEUTICALS INC12 citations74
US5985664ANov 16, 1999

Antisense modulation of Sentrin expression

ISIS PHARMACEUTICALS INC8 citations74
US5962671AOct 5, 1999

Antisense modulation of fan expression

ISIS PHARMACEUTICALS INC6 citations74
US5948680ASep 7, 1999

Antisense inhibition of Elk-1 expression

ISIS PHARMACEUTICALS INC16 citations74
US5643780AJul 1, 1997

Compositions and methods for modulating RNA activity through modification of the 5' cap structure of RNA

ISIS PHARMACEUTICALS INC7 citations74
US6399297B1Jun 4, 2002

Antisense modulation of expression of tumor necrosis factor receptor-associated factors (TRAFs)

ISIS PHARMACEUTICALS INC11 citations70
US6399379B1Jun 4, 2002

Antisense modulation of interleukin 12 p35 subunit expression

ISIS PHARMACEUTICALS INC2 citations63
US6355438B1Mar 12, 2002

Method for quantitating oligonucleotides

ISIS PHARMACEUTICALS INC4 citations61
US7700574B2Apr 20, 2010

Modulation of RANKL expression

ISIS PHARMACEUTICALS INC1 citations50
US6586245B2Jul 1, 2003

Antisense modulation of CD40 ligand expression

ISIS PHARMACEUTICALS INC0 citations40

IONIS PHARMACEUTICALS INC

4 patents

ALLERSON CHARLES

3 patents

YU ZHENGRONG

1 patent

MONIA BRETT P

1 patent

BAKER BRENDA F

1 patent